Figure 2.
High levels of intratumoral ISG transcripts predict prolonged survival in advanced melanoma.
Melanoma patients in the TCGA database were dichotomized by above or below median mRNA expression of the ISGs (a) CXCL10, (b) CCL2, (c) PDCD1LG2, (d) IFNG or (e) 0–1 or 2–4 of these ISGs, followed by analysis of overall survival by the log-rank test (n = 470).